Sign in

CIK 0001087294

  • Non-accelerated filer
  • Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
Operating
EIN
621765329
Phone
+1 615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Gift Chairman and CEO gave 60,000 shares (gift)
  2. 4 Grant or award Sr VP/Chief Commercial Officer acquired 1,950 shares (grant or award)
  3. 4 Grant or award SVP and Chief Development Off. acquired 6,500 shares (grant or award)
  4. 4 Grant or award VP and Chief Compliance Office acquired 5,775 shares (grant or award)
  5. 4 Open-market sale Director sold 4,000 shares at $5.61 ($22,440)
  6. 4 Open-market sale Director sold 6,000 shares at $6.88 ($41,280)
  7. 4 Option exercise Director acquired 700 shares (option exercise)
  8. 4 Grant or award SVP and Chief Development Off. acquired 5,000 shares (grant or award)
  9. 4 Grant or award Sr VP/Chief Commercial Officer acquired 3,000 shares (grant or award)
  10. 4 Grant or award VP and Chief Compliance Office acquired 4,000 shares (grant or award)
  11. 4 Grant or award Chairman and CEO acquired 100,000 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 3,000 shares (grant or award)
  13. 4 Grant or award Director acquired 1,000 shares (grant or award)
  14. 4 Grant or award Director acquired 1,000 shares (grant or award)
  15. 4 Grant or award Director acquired 11,000 shares (grant or award)
  16. 4 Grant or award Director acquired 1,000 shares (grant or award)
  17. 4 Grant or award Director acquired 1,000 shares (grant or award)
  18. 4 Open-market sale Director sold 6,000 shares at $6.95 ($41,700)
  19. 4 Open-market sale Director sold 10,000 shares at $5.12 ($51,200)
  20. 4 Open-market sale Director sold 15,000 shares at $5.08 ($76,200)

Page 20 of 26 · 512 filings